Hasil Pencarian - Ambrose CS
Anda harus masuk terlebih dahulu
- Menampilkan 1 - 9 hasil dari 9
-
1
-
2
Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types oleh Panettieri R Jr, Lugogo N, Corren J, Ambrose CS
Diterbitkan 2024-03-01Dapatkan teks lengkap
Artikel -
3
-
4
Patient and physician preferences for attributes of biologic medications for severe asthma oleh Gelhorn HL, Balantac Z, Ambrose CS, Chung YN, Stone B
Diterbitkan 2019-07-01Dapatkan teks lengkap
Artikel -
5
Health-Related Quality of Life and Productivity Among US Patients with Severe Asthma oleh Soong W, Chipps BE, O'Quinn S, Trevor J, Carr WW, Belton L, Trudo F, Ambrose CS
Diterbitkan 2021-06-01Dapatkan teks lengkap
Artikel -
6
Quality of Life Improvements with Biologic Initiation Among Subspecialist-Treated US Patients with Severe Asthma oleh Soong W, Chipps BE, Carr W, Trevor J, Patel A, Clarke N, Carstens DD, Ambrose CS
Diterbitkan 2024-05-01Dapatkan teks lengkap
Artikel -
7
-
8
Reduced Effectiveness of Anti-IgE Treatment Among Adults with Severe Asthma with Older Age of Asthma Onset: Results from the CHRONICLE Study oleh Ledford DK, Carr WW, Moore WC, Lugogo NL, Mohan A, Chipps B, Mackie AR, Lindsley AW, Spahn J, Ambrose CS
Diterbitkan 2024-10-01Dapatkan teks lengkap
Artikel -
9
Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study oleh Menzies-Gow AN, McBrien C, Unni B, Porsbjerg CM, Al-Ahmad M, Ambrose CS, Dahl Assing K, von Bülow A, Busby J, Cosio BG, FitzGerald JM, Garcia Gil E, Hansen S, Heaney LG, Hew M, Jackson DJ, Kallieri M, Loukides S, Lugogo NL, Papaioannou AI, Larenas-Linnemann D, Moore WC, Perez-de-Llano LA, Rasmussen LM, Schmid JM, Siddiqui S, Alacqua M, Tran TN, Suppli Ulrik C, Upham JW, Wang E, Bulathsinhala L, Carter VA, Chaudhry I, Eleangovan N, Murray RB, Price CA, Price DB
Diterbitkan 2022-01-01Dapatkan teks lengkap
Artikel